SCHEMBL3481694

SCHEMBL3481694

CCCC(C)(CC)O[SiH3]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2770207 0.88 LMNA (0.30)
SCHEMBL7014044 0.84 TSHR (0.33)
SCHEMBL3481656 0.84
SCHEMBL26113601 0.82 TSHR (0.38)
SCHEMBL26113457 0.82 TSHR (0.38)
SCHEMBL2333576 0.82
SCHEMBL3482190 0.79
SCHEMBL17233353 0.77 TSHR (0.33)
SCHEMBL8374429 0.75 TSHR (0.32)
SCHEMBL5154689 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106566855-A Nucleic acid amplification using reversibly modified oligonucleotide 毕万里 2017-04-19 CN claimed
CN-113677364-B Pharmaceutical compositions comprising anti-191P 4D12 antibody drug conjugates and methods of use thereof 艾更斯司股份有限公司 2024-07-05 CN disclosed
CN-106563128-B Use of auristatin-based antibody drug conjugates and mTOR-binding inhibitors in the manufacture of a medicament for the treatment of cancer 西雅图遗传学公司 2020-05-22 CN disclosed
CN-105567717-B It is incorporated into the antibody drug conjugates (ADC) of 191P4D12 albumen Algens Co.,Ltd. (US) 2019-10-29 CN disclosed
CN-109963833-A It is used to prepare mono-protected α, ω-Diaminoalkane method 斯索恩生物制药有限公司 2019-07-02 CN disclosed
CN-105722534-B In conjunction with the antibody drug conjugates (ADC) of CD37 albumen 艾更斯司股份有限公司 2019-05-31 CN disclosed
CN-105246866-B The method of synthesis ingenol and its intermediate 利奥实验室有限公司 2017-06-16 CN disclosed
CN-106566855-A Nucleic acid amplification using reversibly modified oligonucleotide 毕万里 2017-04-19 CN disclosed
US-9546237-B2 Stabilization of polymers that contain a hydrolyzable functionality BRIDGESTONE CORPORATION (JP) 2017-01-17 US disclosed
CN-106061965-A Novel pyrazolyl-heteroarylamides as pesticides 拜耳动物保健有限责任公司 2016-10-26 CN disclosed
CN-101175486-A Drug delivery system with chitosan and polyethylene glycol nanoparticles as bioactive molecules ADVANCED IN VITRO CELL TECH (ES) 2008-05-07 CN disclosed
CN-101039701-A Prodrugs and codrug comprising a biocleavable disulfide linker NICHOLAS PIRAMAL INDIA LTD (IN) 2007-09-19 CN disclosed
US-7270916-B2 Recording medium KABUSHIKI KAISHA TOSHIBA (JP) 2007-09-18 US disclosed
US-6899999-B2 Method of manufacturing composite member, photosensitive composition, porous base material, insulating body and composite member KABUSHIKI KAISHA TOSHIBA (JP) 2005-05-31 US disclosed
US-20050026079-A1 Recording medium PARALLEL WIRELESS, INC. 2005-02-03 US disclosed
CN-1568190-A Combination therapy comprising glucose reabsorption inhibitor and PPAR modulator ORTHO MCNEIL PHARM INC (US) 2005-01-19 CN disclosed
US-20030022102-A1 Method of manufacturing composite member, photosensitive composition, porous base material, insulating body and composite member KABUSHIKI KAISHA TOSHIBA (JP) 2003-01-30 US disclosed
CN-1304306-A Method for inhibiting MRP1 LILLY CO ELI (US) 2001-07-18 CN disclosed
CN-1254280-A A regioselective alkylation process for preparing substituted benzo [b] thiophenes LILLY CO ELI (US) 2000-05-24 CN disclosed
CN-1252717-A Intermediate and method for preparing benzo [ b ] thiophene LILLY CO ELI (US) 2000-05-10 CN disclosed